Skip to main content
Equibles

Eversept Partners, LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1697013 NEW YORK, NY
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,268,078
+$1,316,537 QoQ
Shares Held
831,142
+16.5% QoQ
Ownership
0.734%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#38
of 215 holders
Holding Since
Sep 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. VRDN ranks #12 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,268,078 831,142
2026-03-31 $13,951,541 713,269
2025-12-31 $55,463,153 1,782,235
2025-09-30 $41,526,523 1,924,306
2025-06-30 $26,597,495 1,902,539
2025-03-31 $18,571,045 1,377,674
2024-12-31 $14,952,561 779,998
2024-09-30 $15,725,528 691,232
2024-06-30 $7,383,005 567,487
2024-03-31 $2,487,733 142,075
2023-12-31 $2,991,330 137,343
2023-09-30 $6,799,761 443,270
2022-09-30 $9,811,717 478,387
2022-06-30 $5,155,499 445,592
2022-03-31 $2,879,688 155,743
2021-12-31 $3,847,024 194,589
2021-09-30 $2,632,000 160,000